Contract facts
Small businessNo full NAICS 541714 intel page yet. Browse NAICS intelligence
PERFORM A STRUCTURE ACTIVITY RELATIONSHIP (SAR), MOLECULAR BINDING AND METABOLISM OF THE LEAD SCAFFOLD (HS-176) TO GUIDE THE DEVELOPMENT OF MORE POTENT AND DRUG LIKE ANALOGS, AND PRIORITIZATION OF LEAD ANALOGS THROUGH IN VITRO EFFICACY SCREENING AND is a federal Small business award for National Institutes Of Health Niaid held by Eydis Bio, Inc. Estimated value $500K ($500K obligated). Current period of performance ends Oct 31, 2026. Last award drew 1 bidder. Place of performance: DURHAM NC. Related solicitation PHS 2025-1.
PERFORM A STRUCTURE ACTIVITY RELATIONSHIP (SAR), MOLECULAR BINDING AND METABOLISM OF THE LEAD SCAFFOLD (HS-176) TO GUIDE THE DEVELOPMENT OF MORE POTENT AND DRUG LIKE ANALOGS, AND PRIORITIZATION OF LEAD ANALOGS THROUGH IN VITRO EFFICACY SCREENING AND
Recompete timing
PublicCurrent PoP ends Oct 31, 2026 (34 days remaining). Agencies typically plan 12–18 months ahead — at 1.1 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 75N93025C00040? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordEydis Bio, Inc — $500K obligated across 1 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N93025C00040?
75N93025C00040 (SAR hs-176 and and and and) is a National Institutes Of Health Niaid award with a potential value of $500K, currently held by Eydis Bio, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N93025C00040?
National Institutes Of Health Niaid awarded 75N93025C00040 to Eydis Bio, Inc (potential $500K).
Who is the incumbent on 75N93025C00040?
Eydis Bio, Inc is the incumbent with $500K across 1 related awards in SCOUT’s public footprint. The current period of performance ends Oct 31, 2026.
When does Eydis Bio, Inc’s 75N93025C00040 come up for recompete?
SCOUT tracks a period-of-performance end of Oct 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75N93025C00040? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.